Work

Abstract PD1-05: Real-world adoption, disparities and impact of neoadjuvant chemoimmunotherapy (NACT-IO) in early-stage, high-risk triple negative breast cancer (TNBC)

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd1-05

Authors: I. Jackson, X. Lei, M. Sullivan, S. H. Giordano, M. Chavez-MacGregor

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W7129549799

Cites:

Cited by:

Related to: